Corporate

MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human

At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences,

We are pleased to share a recent publication in conjunction with the UK Health Security Agency (UKHSA) and insights from

MAC Clinical Research’s Manchester site is an MHRA audited and accredited Phase I centre located within and supported by the

As well as working towards being a more sustainable company, there is a big drive for us to pass this

MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in a phase

MAC Clinical Research is pleased to announce that we have joined the United Nations Global Compact initiative — a voluntary

Clinical trials are a costly business, but with trial quality being so critical to patient safety and data integrity, getting

Join us on 20th May to celebrate Clinical Trials Day! A day when the clinical research industry comes together to

Dementia is a complex condition that causes a decline in cognitive abilities and interferes with daily life. It affects memory,